» Articles » PMID: 38765385

The Accelerated Onset of Calciphylaxis in a 72-Year-Old Female Hemodialysis Patient

Overview
Journal Cureus
Date 2024 May 20
PMID 38765385
Authors
Affiliations
Soon will be listed here.
Abstract

Calciphylaxis is a unique medical condition characterized by calcification of the medial layer of arterioles and soft tissues in a patient's skin at the level of the dermis and subcutaneous adipose tissue. The rate of progression of calciphylaxis is rapid, starting with a reduction of blood flow that leads to ischemic changes in the skin that can manifest as painful cutaneous erythematous nodules or plaques and later as skin ulceration. The majority of patients affected by calciphylaxis have predisposing comorbidities such as end-stage renal disease with a long history of hemodialysis and electrolyte abnormalities in calcium, phosphate, and parathyroid hormone levels. This report presents the case of a 72-year-old female patient on hemodialysis who developed calciphylaxis. The methods for early prognosis (the methods of early diagnosis), including clinical presentation, risk factors, imaging techniques, and laboratory investigations, are discussed. The presented case is particularly noteworthy given the onset of calciphylaxis within a mere three months of initiating hemodialysis, a timeline significantly shorter than the typically observed period in most patients. (The case detailed in this report outlines the rapid onset of calciphylaxis in a patient who was receiving hemodialysis for only three months.) This patient with early-onset calciphylaxis highlights the unpredictable nature of calciphylaxis and the need for increased clinical vigilance even in the initial stages of hemodialysis.

References
1.
Ritter C, Slatopolsky E . Phosphate Toxicity in CKD: The Killer among Us. Clin J Am Soc Nephrol. 2016; 11(6):1088-1100. PMC: 4891758. DOI: 10.2215/CJN.11901115. View

2.
Jean G, Bresson E, Terrat J, Vanel T, Hurot J, Lorriaux C . Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant. 2008; 24(3):948-55. DOI: 10.1093/ndt/gfn571. View

3.
Selye H, Gentile G, Prioreschi P . Cutaneous molt induced by calciphylaxis in the rat. Science. 1961; 134(3493):1876-7. DOI: 10.1126/science.134.3493.1876. View

4.
Nigwekar S, Bloch D, Nazarian R, Vermeer C, Booth S, Xu D . Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis. J Am Soc Nephrol. 2017; 28(6):1717-1722. PMC: 5461787. DOI: 10.1681/ASN.2016060651. View

5.
Nigwekar S, Wolf M, Sterns R, Hix J . Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008; 3(4):1139-43. PMC: 2440281. DOI: 10.2215/CJN.00530108. View